CEO INTERVIEW: GEORGE CWYNAR - MOSAID TECHNOLOGIES INC (MDS:TSE).(PAF PAF platelet activating factor. PAF abbr. platelet-aggregating factor PAF platelet activating factor. 209) GEORGE CWYNAR - MOSAID TECHNOLOGIES INC (MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there :TSE). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Semiconductors. Published date 4/9/02. Tickers featured: MDS:TSE. Complete text approximately 3000 words. Document # PAF209. CEO INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion